Celanese Corporation, a global specialty materials and chemical company, featured an expanded portfolio of polymer solutions for the healthcare market during the recently concluded Medtec China 2023 in Suzhou, China.

In addition to its comprehensive, proven and trusted portfolio of medical plastics, Celanese now offers Zytel Resin, Hytrel TPC, Crastin PBT and Micromax Electronic Inks and Paste following its 2022 acquisition of the majority of the Mobility & Materials (M&M) business from DuPont.

"We are proud to introduce this larger product portfolio to the healthcare industry to improve patients' lives and enable our customers' sustainable growth," said Dongman Shin, Asia Pacific application development director, Industrial Medical Consumer business for the engineered materials business of Celanese.

As more patients deal with chronic conditions, the healthcare industry is innovating with devices that make at-home care and self-administration more convenient, safe and comfortable. Celanese medical-grade resins enable medical and pharma companies to design devices to improve patients' quality of life.

"With a 40-year track record of providing safe, high-performance materials to the healthcare industry, Celanese offers the technical and applications development capabilities to help customers advance their healthcare and medical products from design to market," said Eric Wang, Asia Pacific development director, Industrial Medical Consumer business for the engineered materials business of Celanese.

In addition to solutions for drug delivery devices and orthopedic implants, Celanese will showcase materials for primary packaging and fluid handling solutions. Celanese invites visitors to Medtec China 2023 to booth B1-F402 to see the latest in powerful brands and smart material solutions for the healthcare market.